By Fink Densford TransEnterix (NYSE:TRXC) said yesterday that it’s looking for $50 million from a follow-on offering of common stock to finance the sales and marketing of its SurgiBot robot-assisted surgery device. The Research Triangle Park, N.C.-based company has not yet revealed the